Categories

Category: Uncategorized

IDIH Week 2022 on Active and Heathy Aging in Time of COVID– including US workshop 12 ET/9PT, Monday 21st

By ELIZABETH BROWN for CATALYST @ HEALTH 2.0

IDIH Week 2022 starts this coming Monday! It is a 4-day FREE online event hosted by Catalyst & our partner organizations that is dedicated to researchers, innovators, care providers and users associations dealing with Digital Health for Active and Healthy Ageing (AHA). IDIH Week is a unique occasion for R&I stakeholders from the US, Europe, and beyond to explore opportunities for international cooperation in the field of Digital Health for Active and Healthy Ageing, through information, networking and co-creation sessions that will be held between March 21 and March 24.

The team at Catalyst will be running a US Regional Workshop on Monday from 12pm ET/9am PT – 2pm ET/11am PT. The Workshop, titled The Impact of COVID-19 on the Shared Priorities for International Cooperation in Active and Healthy Ageing, aims to bring a US perspective to the findings of the IDIH Digital Health Transformation Forum around the areas of data governance, interoperability by design, and digital inclusion, and how these have been impacted by COVID-19. Check out the IDIH Week agenda available here.

Panelists for the workshop are author, healthcare journalist, educator, and activist Nancy B. Finn, health lawyer and privacy expert Deven McGraw, innovation consultant and digital health strategist Iana Simeonov, specialist in media and gerontology Mandy Salomon, and smart home and aging expert George Demiris. Catalyst’s Indu Subaiya & Matthew Holt will be moderating the discussion.

Register for IDIH Week 2022 here

To join us: If you are not registered to the IDIH Platform: register here and select the sessions of the IDIH Week 2022 in which you are interested.If you are already registered in the IDIH Platform: access your Agenda and add the sessions of the IDIH Week 2022 in which you are interested.

More details on IDIH Week below

Continue reading…

Quickbite Interviews: Force Therapeutics/Xealth & Avia Health

I was at the VIVE conference in Miami last week and caught up with a number of CEOs & execs for some quickbite interviews — around 5 mins getting (I hope) to the gist of what they & their companies are up to. I am going to dribble them out this week.

Up here are Mikayla McGrath, Head of Partnerships at Force Therapeutics & Cynthia Church, Chief Strategy Officer at Xealth–they’re on together discussing their partnership. The other bite is with Cynthia Perazzo, EVP Insights, AVIA Health, who is telling us about the transformation she is seeing among American’s hospital systems. — Matthew Holt

The (sort of, partial) Father mRNA Vaccines Who Now Spreads Vaccine Misinformation (Part 2)

By DAVID WARMFLASH, MD

This is part 2 of David Warmlash’s takedown of Robert W. Malone’s appearance (transcript) on the Rogan podcast. Part 1 is here

Menstruation and Fertility

Much more than the line about reproductive damage in the Wisconsin News clip that we used to open the story, Malone used the Rogan interview to dive more deeply into the topic, starting with:

 …there’s a huge number of dysmenorrhea and menometrorrhagia…

By that, he meant excessive menstrual cramping and very heavy, often irregular, bleeding, which he followed up with:

…they DENY it…

Judging by other parts of the interview, ‘they’ means government health agencies, big pharma, mainstream media. Thus, it was quite an accusation, given that, months prior to Malone’s talk with Rogan, the National Institutes of Health (NIH) had announced a program to study COVID-19 vaccination effects in pregnant and postpartum women and then announced, very publicly, that it had awarded $1.67 million to five institutions (Boston University, Harvard Medical School, Johns Hopkins University, Michigan State University, and Oregon Health and Science University [OHSU]) to study vaccines and the menstrual cycle.

Rather than bringing up any of that NIH-funded research, however, Malone jumped into a description of haredi rabbis asking him to ‘testify’ at a rabbinical ‘court’ in Brooklyn:

..it turns out that the rabbis in the Hasidic jew community carefully monitor–we don’t need to go into how–the menstrual cycle of the fertile women in their congregations, closely monitor it because there is strict guidance about cleanliness and intercourse and they had a major problem because they these you know these are all 60 plus up to 80 long beards right here that had exquisite understanding about the menstrual cycle in all the women in their congregations and they all knew that these menstrual cycles were being disrupted all the time…

What a load of mishigas.

Continue reading…

#HealthTechDeals Episode 16: Doctolib, House Rx, SmithRx, Synapse Medicine, and Kintsugi

May the luck of the Irish be with the health tech sector and may everybody’s valuation go back to where it was for the St. Patrick’s Day episode of Health Tech Deals! In today’s episode, Jess asks me about Doctolib’s €500 million raise with a massive €5.8 billion valuation – this is a doctor booking service and more in Europe. We also cover specialty pharma company House Rx’s $25 million raise, bringing their total up to $30 million, SmithRx’s $27 million raise for its flat-fee PBM, Synapse Medicine’s $28 million raise doing medication management, and Kintsugi’s $20 million raise for its voice biomarker mental health tech. —Matthew Holt

TRANSCRIPT

Jessica DaMassa:

What’s that over there? Is that a little leprechaun sitting next to a pot of gold at the end of a rainbow? No, it’s just Matthew Holt. May the luck of the Irish be with the health tech sector and everybody’s valuation goes back to where it was in the summer of 2021. It can only be the March 17th ,St. Patty’s day, episode of Health Tech Deals.

Matthew Holt:

So, Jessica you’re from Chicago, right?

Jessica DaMassa:

I am.

Matthew Holt:

And they have the big St. Patrick’s Day Parade there and they dye the river green?

Jessica DaMassa:

They dye the river green. Nobody believes it but it’s true.

Matthew Holt:

So why don’t they dye it blue the rest of the year?

Continue reading…

“There Isn’t One Health Plan to Save Them All”: Flume Health’s CEO on New Build-A-Plan Biz

By JESSICA DaMASSA, WTF HEALTH

Two of the most notable payer venture funds, Optum Ventures and Cigna Ventures, just headed up a $30 million dollar Series A funding round for Flume Health, a startup that basically builds “challenger” health plans. How did this go down? Cédric Kovacs-Johnson CEO & Founder of Flume introduces us to his company which offers providers, digital health co’s, brokers, reinsurers, and just about any other healthcare org a tech stack for creating their own hyper-niche, super personalized health plans.

The suite of services to “build-a-plan” includes things like claim processing, payments, enrollment management, digital health point solutions integration, and other API functionality – replacing the traditional TPA with tech and the one-size-fits-all plan with a new opportunity for nichey-ness that can customize coverage for patient populations based on health conditions, location, employer, and so on.

Cédric talks us through the benefit to his target client – the care provider – who, while taking on more risk anyway, may consider building their own plan to capture more premium dollars and gain better control over the end-to-end patient experience. Wait a minute – is all this “Challenger Health Plan” talk just a re-brand of value-based care? I ask point-blank and get a new buzz phrase in return; welcome to the lexicon, “Commercial Advantage.” Lots to unpack in this one including Flume’s rev-gen model and plans for growth – they’re already onboarding one new challenger plan per month!

The (sort of, partial) Father mRNA Vaccines Who Now Spreads Vaccine Misinformation (Part 1)

By DAVID WARMFLASH, MD

Robert W. Malone, MD MS, is a physician-scientist who will live in infamy, thanks to the Joe Rogan Experience Podcast boosting his visibility this past December regarding his criticism of COVID-19 vaccines, particularly the mRNA vaccines (Moderna and Pfizer-BioNTech). Subsequently, Malone was banned from Twitter, which further boosted his celebrity status. Describing himself as the inventor of mRNA vaccine technology, he has been reaching a growing number of people with a narrative that makes COVID-19 vaccination sound scary. We cannot embed clips from the Rogan interview, which lasted about three hours, because it is accessed only on Spotify. But we can pull quotes from the interview transcript and we can see how Malone addresses non-scientists in shorter appearances, like the following clip from Wisconsin Morning news aimed at parents:

…Before you inject your child – a decision that is irreversible – I wanted to let you know the scientific facts about this genetic vaccine, which is based on the mRNA vaccine technology I created…

There are three issues parents need to understand:

The first is that a viral gene will be injected into your childrens cells. This gene forces your childs body to make toxic spike proteins. These proteins often cause permanent damage in childrens critical organs, including

Their brain and nervous system

Their heart and blood vessels, including blood clots

Their reproductive system

And this vaccine can trigger fundamental changes to their immune system

The most alarming point about this is that once these damages have occurred, they are irreparable

You cant fix the lesions within their brain

You cant repair heart tissue scarring

You cant repair a genetically reset immune system, and

This vaccine can cause reproductive damage that could affect future generations of your family….

Along with the alarmist theme, there are some phrases in the excerpt that people with little knowledge of biology could take the wrong way. The ‘toxic’ spike protein terminology warrants unpacking later, because Malone’s more farfetched ideas rest upon his disagreement with experts who have worked on that very spike protein. This is a protein that SARS-CoV2 (the virus that causes COVID-19) makes and uses to enter body cells, and is the basis of most of the COVID-19 vaccines that are approved throughout the world. In the case of the genetic vaccines (the mRNA vaccines of Pfizer-BioNTech and Moderna and the viral vector vaccines of Johnson and Johnson and AstraZeneca), the vaccines do not actually contain spike protein. Instead, they contain a recipe for cells of a vaccinated person (not all the person’s cells, but just a small sampling) to make spike protein —in very small amounts and for a very limited time— and display it on the outer part of their cell membranes. This allows the immune system to use that vaccine-generated spike protein for target practice, so you can build immunity against the virus without the virus infecting you.

Continue reading…

Quickbite Interviews: 1UpHealth& Cecelia Health

I was at the VIVE conference in Miami last week and caught up with a number of CEOs & execs for some quickbite interviews — around 5 mins getting (I hope) to the gist of what they & their companies are up to. I am going to dribble them out this week.

Up here are are Joe Gagnon, CEO, 1upHealth, a data integrator that works primarily with health plans, and Mark Clermont, CEO, Cecelia Health, a chronic care management company that also runs pharma patient adherence programs. — Matthew Holt

Clarify Health Solutions’ CEO on Data Analytics Startup’s Next Trick: Value-Based Payments Tech

By JESSICA DaMASSA, WTF HEALTH

Turns out, the Clarify Health Solutions story is about a lot more than data and analytics these days. Value-based payments? Acquisition of provider-focused, behavioral science startup Embedded Healthcare? Opportunities in real-world evidence??

Good thing founder & CEO Jean Drouin and I caught up at ViVE 2022. Not only do we get into the backstory of the business, which has built a self-service analytics platform for payers, providers, and life science co’s on top of “one of the largest-ever patient datasets” in the industry, but we also talk about the strategy that’s driving Clarify into the world of value-based contracting and how Embedded Healthcare’s tech will be used to augment and refine that new offering.

Jean talks in detail about his client mix, business model, and the two “healthcare golden rules” Clarify lives by as it scales up its business: 1) figure out how the payment method is going to work and 2) don’t mess with the work-flow.

#HealthTechDeals Episode 15| Clarify, Embedded Healthcare, Wildflower, Vivante Health, Gravie, Nice

We made it back from ViVE in one piece! Will Jess DaMassa stab me in the back Brutus-Style? Tune in to find out as we discuss deals: Clarify buys Embedded Healthcare; Wildflower raises $26 million; Vivante Health raises $16 million; Gravie raises $75 million; and Nice Healthcare raises $30 million.

Matthew Holt

Transcript

Jess DaMassa:

Well, we made it back from Vive all in one piece and we landed squarely in the Ides of March. Will I stab Matthew Holt in the back Brutus-style? Tune to the March 15th episode of Health Tech DEALS. Oh Matthew Holt, those ruthless Romans, never trust an Italian. That’s the lesson here.

Matthew Holt:

Well, sad enough, I trusted you and you told me to buy some stocks. And now, have you seen digital digital health talks yesterday?

Matthew Holt:

Everybody off another 10%?

Jess DaMassa:

Okay, but how does that compare with the reality of everything else right now?

Matthew Holt:

I don’t know. Somehow, Teladoc was about 300 a year ago

Jess DaMassa:

Don’t even talk to me about Teladoc.

Matthew Holt:

Now it’s around 50.

Continue reading…

#HealthTechDeals Episode 14: Elemy, Health Gorilla, M_disrupt; Flume; and Homeward Health

In this episode of Health Tech Deals, Jess and I say hello to you from Miami! Together at ViVE 2022, we weigh in on some big funding deals! We also have a short cameo along the way (watch to see who it is)! Elemy raises $215 million; Health Gorilla raises $50 million; M_disrupt raises $6 million; Flume raises $30 million; and Homeward Health raises $20 million.

TRANSCRIPT

Jessica DaMassa:

Hello from Miami. I am at ViVE and look, the exhibit hall coming down around me. Here’s what the reg area looked like. People are leaving, everybody’s got their bags and ah, look who I’ve got. Weighing in with the big funding deals from ViVE, Matthew Holt. It is the March 10th episode of Health Tech Deals. Well, we’re selfie-style here, because we are on the move.

Matthew Holt:

Yeah. You had a fantastic professional cameraman and we decided not to use him

Jessica DaMassa:

No. Instead we’re using this, but I’ve interviews for you guys coming out of this.

Matthew Holt:

Even I did some, actually a lot of stuff going on in the show, pretty interesting. And there were a few deals announced.

Continue reading…